title: Age-related macular degeneration.
abstract: OBJECTIVE
  Is there any new knowledge about the pathogenesis and treatment of age-related macular degeneration (AMD)?
  
  
  RESULTS
  We now understand better the biochemical and pathological pathways involved in the genesis of AMD. Treatment of exudative AMD is based on intravitreal injection of new antivascular endothelial growth factor drugs for which there does not yet exist a unique recognized strategy of administration. No therapies are actually available for atrophic AMD, despite some experimental new pharmacological approaches.
  
  
  METHODS
  strategy of administration, safety of intravitreal injection.
authors.affiliation: Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris-Est Créteil, Créteil, France;
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Querques
authors.forename: Fernando Onofrio
authors.initials: FO
authors.lastname: Avellis
authors.forename: Lea
authors.initials: L
authors.lastname: Querques
authors.forename: Francesco
authors.initials: F
authors.lastname: Bandello
authors.forename: Eric H
authors.initials: EH
authors.lastname: Souied